Total Payments
$9,763
2024 Payments
$1,617
Companies
36
Transactions
555
Medicare Patients
3,419
Medicare Billing
$459,897
Payment Breakdown by Category
Food & Beverage$8,042 (82.4%)
Consulting$1,703 (17.4%)
Education$17.01 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,042 | 551 | 82.4% |
| Consulting Fee | $1,703 | 2 | 17.4% |
| Education | $17.01 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $2,888 | 70 | $0 (2024) |
| Novo Nordisk Inc | $1,046 | 118 | $0 (2024) |
| ABBVIE INC. | $1,039 | 93 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $705.37 | 49 | $0 (2024) |
| Lilly USA, LLC | $671.05 | 28 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $456.72 | 27 | $0 (2024) |
| Abbott Laboratories | $381.23 | 20 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $341.58 | 21 | $0 (2020) |
| Amgen Inc. | $305.22 | 16 | $0 (2024) |
| PFIZER INC. | $223.66 | 18 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,617 | 108 | ABBVIE INC. ($400.90) |
| 2023 | $2,003 | 122 | AbbVie Inc. ($533.54) |
| 2022 | $3,214 | 123 | Takeda Pharmaceuticals U.S.A., Inc. ($2,068) |
| 2021 | $594.50 | 55 | Novo Nordisk Inc ($351.05) |
| 2020 | $1,024 | 59 | Takeda Pharmaceuticals U.S.A., Inc. ($148.55) |
| 2019 | $39.91 | 3 | Amgen Inc. ($16.42) |
| 2018 | $109.68 | 6 | Lilly USA, LLC ($40.69) |
| 2017 | $1,160 | 79 | SANOFI-AVENTIS U.S. LLC ($196.13) |
All Payment Transactions
555 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 12/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.00 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/12/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: Diabetes Care | ||||||
| 12/11/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $34.91 | General |
| Category: RESPIRATORY | ||||||
| 12/11/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $6.22 | General |
| Category: Inflammation | ||||||
| 12/10/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $7.99 | General |
| Category: NEUROSCIENCE | ||||||
| 12/06/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $9.39 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $8.39 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $25.79 | General |
| Category: IMMUNOLOGY | ||||||
| 11/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: Cardio-renal | ||||||
| 11/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $8.41 | General |
| Category: Cardio-renal | ||||||
| 10/30/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: Diabetes | ||||||
| 10/24/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $29.88 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $9.69 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: Respiratory | ||||||
| 10/11/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $26.96 | General |
| Category: VACCINES | ||||||
| 10/09/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $26.25 | General |
| Category: NEUROSCIENCE | ||||||
| 10/04/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: VACCINE | ||||||
| 10/02/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $26.80 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/01/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $6.97 | General |
| Category: NEUROSCIENCE | ||||||
| 09/25/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $26.33 | General |
| Category: NEUROSCIENCE | ||||||
| 09/24/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $9.38 | General |
| Category: NEUROSCIENCE | ||||||
| 09/18/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,074 | 1,493 | $301,361 | $146,578 |
| 2022 | 19 | 984 | 27,880 | $316,923 | $137,651 |
| 2021 | 16 | 799 | 1,288 | $243,108 | $105,644 |
| 2020 | 11 | 562 | 902 | $175,379 | $70,023 |
Total Patients
3,419
Total Services
31,563
Medicare Billing
$459,897
Procedure Codes
61
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 184 | 527 | $124,899 | $48,132 | 38.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 130 | 130 | $43,160 | $36,718 | 85.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 139 | 139 | $33,082 | $18,879 | 57.1% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 165 | 165 | $31,515 | $13,159 | 41.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 36 | 56 | $17,080 | $7,425 | 43.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 130 | 130 | $6,110 | $4,225 | 69.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 16 | 17 | $10,761 | $3,719 | 34.6% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 48 | 48 | $3,984 | $3,628 | 91.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 30 | 35 | $5,635 | $2,523 | 44.8% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 13 | 13 | $3,634 | $2,257 | 62.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 18 | 18 | $6,390 | $2,081 | 32.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 52 | 52 | $2,444 | $1,690 | 69.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 85 | 91 | $6,370 | $974.13 | 15.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 17 | 59 | $4,543 | $596.40 | 13.1% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 11 | 13 | $1,754 | $572.78 | 32.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 177 | 636 | $150,732 | $63,064 | 41.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 136 | 136 | $32,368 | $18,993 | 58.7% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 152 | 152 | $29,032 | $12,954 | 44.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 46 | 73 | $22,265 | $10,447 | 46.9% |
| 90670 | Pneumococcal vaccine, 13-valent | Office | 2022 | 22 | 22 | $10,670 | $5,303 | 49.7% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 16 | 21 | $11,313 | $5,014 | 44.3% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 61 | 61 | $4,612 | $4,278 | 92.7% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 25 | 25 | $6,325 | $3,295 | 52.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 33 | 38 | $6,118 | $2,614 | 42.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 68 | 68 | $3,196 | $2,175 | 68.1% |
About Dr. John Testa, MD
Dr. John Testa, MD is a Internal Medicine healthcare provider based in Prospect, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1609835735.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Testa, MD has received a total of $9,763 in payments from pharmaceutical and medical device companies, with $1,617 received in 2024. These payments were reported across 555 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($8,042).
As a Medicare-enrolled provider, Testa has provided services to 3,419 Medicare beneficiaries, totaling 31,563 services with total Medicare billing of $459,897. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Prospect, CT
- Active Since 03/18/2006
- Last Updated 10/28/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1609835735
Products in Payments
- GLASSIA (Biological) $2,637
- Kerendia (Drug) $705.37
- Ozempic (Drug) $649.84
- UBRELVY (Drug) $377.80
- MOUNJARO (Drug) $369.39
- QULIPTA (Drug) $363.36
- JARDIANCE (Drug) $320.55
- Rybelsus (Drug) $294.51
- FARXIGA (Drug) $237.48
- Otezla (Drug) $186.46
- HYQVIA (Biological) $171.91
- FREESTYLE LIBRE 3 (Device) $169.63
- VRAYLAR (Drug) $155.15
- SOLIQUA 100/33 (Biological) $145.45
- SYNTHROID (Drug) $126.32
- Vascepa (Drug) $118.91
- TOUJEO (Drug) $111.93
- Trintellix (Drug) $110.80
- CeQur Simplicity (Device) $110.19
- BREZTRI (Drug) $105.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Prospect
Dr. Tina Yuan, M.d, M.D
Internal Medicine — Payments: $17,335
Internal Medicine $17,335
Dr. Jennifer Walden-Fain, M.d, M.D
Internal Medicine — Payments: $11,893
Internal Medicine $11,893
Carlos Almeida, Md, MD
Internal Medicine — Payments: $9,387
Internal Medicine $9,387
Dr. Jeffrey Omer, Md, MD
Internal Medicine — Payments: $9,269
Internal Medicine $9,269
Dr. Michael Chesnut, M.d, M.D
Internal Medicine — Payments: $9,021
Internal Medicine $9,021
James Uberti, Md, MD
Internal Medicine — Payments: $8,887
Internal Medicine $8,887